Publications by authors named "Peter D Emanuel"

Claim this Profile
J
Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell-mediated lysis and express targetable antigens.
Shannalee Martinez, Vladimir V Senyukov, Suheyla Hasgur, Arianexys Aquino-López, Peter D Emanuel

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions.
Tamara Westover, Michael P Walsh, Sherif Abdelhamed, Emily Xiong, Jing Ma, Peter D Emanuel

Blood Neoplasia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age-specific mouse model.
Nitza Vara, Yuqing Liu, Yan Yan, Shelly Y Lensing, Natalia Colorado, Peter D Emanuel

Blood Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia.
Jingliao Zhang, Zhifu Xiang, Priyangi A Malaviarachchi, Yan Yan, Nicholas J Baltz, Peter D Emanuel

Cell Signal· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Expectations in the Transition to Proof of Concept Studies.
Thomas Kieber-Emmons, Issam Makhoul, Angela Pennisi, Eric R Siegel, Peter D Emanuel

Rev Recent Clin Trials· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion.
Yi Luo, Lijian Shao, Jianhui Chang, Wei Feng, Y Lucy Liu, Peter D Emanuel

Blood Adv· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.
Laura F Hutchins, Issam Makhoul, Peter D Emanuel, Angela Pennisi, Eric R Siegel

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy.
Y Lucy Liu, Yan Yan, Cody Webster, Lijian Shao, Shelly Y Lensing, Peter D Emanuel

Blood· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia.
Elliot Stieglitz, Amaro N Taylor-Weiner, Tiffany Y Chang, Laura C Gelston, Yong-Dong Wang, Peter D Emanuel

Nat Genet· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving a Carbohydrate Mimetic Peptide into the clinic.
Issam Makhoul, Laura Hutchins, Peter D Emanuel, Angela Pennisi, Eric Siegel

Hum Vaccin Immunother· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic landscape of juvenile myelomonocytic leukemia.
Elliot Stieglitz, Amaro N Taylor-Weiner, Tiffany Y Chang, Laura C Gelston, Yong-Dong Wang, Peter D Emanuel

Nat Genet· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
Elliot Stieglitz, Ashley F Ward, Robert B Gerbing, Todd A Alonzo, Robert J Arceci, Peter D Emanuel

Pediatr Blood Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC amplification in multiple marker chromosomes and EZH2 microdeletion in a man with acute myeloid leukemia.
Zhifu Xiang, Al-Ola Abdallah, Rangaswamy Govindarajan, Paulette Mehta, Peter D Emanuel

Cancer Genet· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome-associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management.
Amelia McDermott, Jennifer Jacks, Marcus Kessler, Peter D Emanuel, Ling Gao

Int J Dermatol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.
Elliot Stieglitz, Camille B Troup, Laura C Gelston, John Haliburton, Eric D Chow, Peter D Emanuel

Blood· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hallway gossip between Ras and PI3K pathways.
Peter D Emanuel

Blood· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in GATA2 are rare in juvenile myelomonocytic leukemia.
Elliot Stieglitz, Y Lucy Liu, Peter D Emanuel, Robert P Castleberry, Todd M Cooper

Blood· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia.
Michael W Deininger, Kenneth J Kopecky, Jerald P Radich, Suzanne Kamel-Reid, Wendy Stock, Peter D Emanuel

Br J Haematol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of proteasome-associated auto-inflammatory syndrome with compound heterozygous mutations.
Amelia McDermott, Adriana Almeida Jesus, Yin Liu, Peter Kim, Jennifer Jacks, Peter D Emanuel

J Am Acad Dermatol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN transcript variants caused by illegitimate splicing in "aged" blood samples and EBV-transformed cell lines.
Yunying Liu, Priyangi Malaviarachchi, Marjorie Beggs, Peter D Emanuel

Hum Genet· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.
Mignon L Loh, Debbie S Sakai, Christian Flotho, Michelle Kang, Manfred Fliegauf, Peter D Emanuel

Blood· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN deficiency is a common defect in juvenile myelomonocytic leukemia.
Yunying Lucy Liu, Robert P Castleberry, Peter D Emanuel

Leuk Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mrtl-A translation/localization regulatory protein encoded within the human c-myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network.
Hyoungsoo Choi, Nateka L Jackson, Denise R Shaw, Peter D Emanuel, Y Lucy Liu

J Cell Biochem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in RNA-binding activities of IRES-regulatory proteins as a mechanism for physiological variability and pathological dysregulation of IGF-IR translational control in human breast tumor cells.
Zheng Meng, Nateka L Jackson, Hyoungsoo Choi, Peter H King, Peter D Emanuel

J Cell Physiol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS pathway mutations in juvenile myelomonocytic leukemia.
Peter D Emanuel

Acta Haematol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis